Immediately after acquiring a drug called Daraprim, Martin Shkreli, founder and CEO of Turing Pharmaceuticals raised the price from $13.50/tablet to $750/tablet. Is this a justifiable price increase as Shkreli suggests, or a text book case of price gouging? Read more here. (Source: Andrew Pollack, The New York Times, 9/20/15)
You are here: / / Which Generic Drug Recently Sold for $13.50 increased to $750 Overnight?